1. Home
  2. GMGI vs ITOS Comparison

GMGI vs ITOS Comparison

Compare GMGI & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMGI
  • ITOS
  • Stock Information
  • Founded
  • GMGI 2008
  • ITOS 2011
  • Country
  • GMGI United States
  • ITOS United States
  • Employees
  • GMGI N/A
  • ITOS N/A
  • Industry
  • GMGI Computer Software: Prepackaged Software
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GMGI Technology
  • ITOS Health Care
  • Exchange
  • GMGI Nasdaq
  • ITOS Nasdaq
  • Market Cap
  • GMGI 255.9M
  • ITOS 270.7M
  • IPO Year
  • GMGI N/A
  • ITOS 2020
  • Fundamental
  • Price
  • GMGI $1.99
  • ITOS $5.68
  • Analyst Decision
  • GMGI Strong Buy
  • ITOS Strong Buy
  • Analyst Count
  • GMGI 1
  • ITOS 3
  • Target Price
  • GMGI $4.00
  • ITOS $26.00
  • AVG Volume (30 Days)
  • GMGI 116.3K
  • ITOS 366.6K
  • Earning Date
  • GMGI 03-24-2025
  • ITOS 03-05-2025
  • Dividend Yield
  • GMGI N/A
  • ITOS N/A
  • EPS Growth
  • GMGI N/A
  • ITOS N/A
  • EPS
  • GMGI N/A
  • ITOS N/A
  • Revenue
  • GMGI $151,115,532.00
  • ITOS $35,000,000.00
  • Revenue This Year
  • GMGI $36.68
  • ITOS N/A
  • Revenue Next Year
  • GMGI N/A
  • ITOS $121.70
  • P/E Ratio
  • GMGI N/A
  • ITOS N/A
  • Revenue Growth
  • GMGI 62.50
  • ITOS 177.89
  • 52 Week Low
  • GMGI $1.70
  • ITOS $5.85
  • 52 Week High
  • GMGI $6.27
  • ITOS $18.75
  • Technical
  • Relative Strength Index (RSI)
  • GMGI 45.63
  • ITOS 27.97
  • Support Level
  • GMGI $2.00
  • ITOS $6.32
  • Resistance Level
  • GMGI $2.18
  • ITOS $6.76
  • Average True Range (ATR)
  • GMGI 0.10
  • ITOS 0.31
  • MACD
  • GMGI -0.01
  • ITOS -0.11
  • Stochastic Oscillator
  • GMGI 31.88
  • ITOS 0.54

About GMGI Golden Matrix Group Inc.

Golden Matrix Group Inc is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. The company operates in two reportable segments; B2B and B2C. The B2C segment earns majority revenue. The company operates in UK, Asia Pacific and Latin America. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, R Kings Competitions and GM-AG.

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

Share on Social Networks: